Barely Significant
← all excerpts

Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer.

Ann Surg Oncol · 2017 · PMC5486922 · PMID 28188501

Europe PMCDOI
1
hedged sentence
0.0730
closest p · 1.5× alpha
0.0730
boldest claim

The sentences

approached significanceP = 0.073so close (0.05 < p ≤ 0.1)
In a multivariate Cox regression analysis that assessed each eligibility criterion separately, only celiac lymph node involvement [hazard ratio (HR) 3.583; 95% CI 1.884–6.814; P = 0.000] was an independent prognostic factor for OS. Disease-Free Survival The difference in DFS between group 1 and 2 approached significance ( P = 0.073; Fig. 1 b), with a median of 42.5 months (95% CI 15.7–69.4 months) in group 1 and 18.2 months (95% CI 7.4–28.9 months) in group 2.

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.